- Drug Manufacturers - General
- Healthcare
Gilead Sciences, Inc.
GILD · US ·
NASDAQ
75.59
USD
+1.59
(2.10%)
-
0.39
EPS
-
194.75
P/E
-
94.2B
MARKET CAP
-
4.02%
DIV YIELD
EPS Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 0.4 | 4.01 | 6.28 | 7.45 | 8.31 | 8.95 | 86.20% |
| Avg. Estimate | 0.389 | 3.76 | 5.14 | 5.51 | 8.08 | 8.7 | 86.20% |
| Low Estimate | 0.379 | 3.33 | 3.05 | 3.06 | 7.87 | 8.47 | 86.20% |
| No. Of Analysts | 19 | 20 | 19 | 15 | 6 | 7 |
Revenue Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 27.6B | 27.8B | 28.7B | 29.4B | 30.5B | 31.7B | 2.80% |
| Avg. Estimate | 27.4B | 27.6B | 27.9B | 28.7B | 29.8B | 31B | 2.48% |
| Low Estimate | 27.3B | 27.1B | 27.4B | 28.2B | 29.2B | 30.4B | 2.21% |
| No. Of Analysts | 21 | 19 | 21 | 23 | 19 | 13 |
Net Income Estimates
| 2023-12-31 | 2024-12-31 | 2025-12-31 | 2026-12-31 | 2027-12-31 | 2028-12-31 | CAGR | |
|---|---|---|---|---|---|---|---|
| High Estimate | 582M | 5.04B | 7.9B | 9.37B | 10.5B | 11.3B | 80.85% |
| Avg. Estimate | 485M | 4.72B | 6.25B | 6.77B | 10.2B | 10.9B | 86.50% |
| Low Estimate | 388M | 4.2B | 3.84B | 3.85B | 9.9B | 10.7B | 93.98% |
| No. Of Analysts | 21 | 19 | 21 | 23 | 19 | 13 |